Recently, Binance finally welcomed the first DeSci project. Many old people should have some impression of it, that is, the BIO protocol. From 2018 to now, the team has been continuously building in biological sciences, and has also cooperated to launch new projects, such as URO and RIF.

From the earliest Molecule to today's BIO, 7 years have passed. Apart from the fact that it is known to the outside world that Binance invested in it, what is it like?

This article sorts out this:

The founder of BIO is an early OG in the circle. He first worked as an investment analyst in the private equity field. After coming into contact with Ethereum in 2016, he started to build a developer community in South Africa to explore Ethereum, during which he received funding from relevant organizations.

He then joined Consensys as business development director and founded Molecule, the predecessor and affiliate of BIO, in 2018.

According to public information, Molecule initially wanted to try to build an IP trading platform by tokenizing the patent IP of biopharmaceutical and research companies to build its own patent token exchange.

Later, as more external VCs joined and the market narrative changed, it began to focus on infrastructure, fundraising platforms and commercial funding.

In September of this year, the Solana Foundation provided a donation to Molecule, which ultimately built the Pump Science launch platform to ensure that experimenters can raise funds for their ideas through MEME launches.

Currently, the platform has launched URO and RIF, both of which are meme-hit tokens on Solana.

In addition, BIO also plans to expand the project to the Solana ecosystem to deploy BIO tokens, build cross-chain bridges, and build related infrastructure. The entire Molecule system is also gradually migrating from Ethereum to Solana.

This may be inseparable from the continued support of the Solana Foundation.

In terms of internal relations, Molecule is more like the parent company of BIO. In the BIO token white paper, 17.6% of the total tokens are attributed to the Molecule Foundation and related investors.

Part of it was also attributed to the holders of VitaDAO and VITA IPT in response to the community's controversy over the team's continuous issuance of new coins.

In terms of market capitalization estimation, BIO's path is reminiscent of CHZ, which used to cooperate with various teams to continuously issue new fan tokens, making it a platform for IP trading and fan economy, while BIO launched DAO tokens in cooperation with scientists in the form of scientific funding.

Currently, BIO plans to launch 15-20 DAO organizations in early 2025. Therefore, the initial market value will be high, and the market will also have expectations for new coins.

However, BIO has also received many community doubts, such as too many internal projects and confusing empowerment and relationships between them. At the same time, too much funding and the issuance of related DAO tokens may dilute the value of the original circulating tokens, such as URO, RIF and VITA.

It reminds people of Animoca’s heyday when it was investing and building projects crazily.

After all, there are praises and there are doubts. The above is a brief review of BIO, Molecule, and related projects.

The DeSci craze this time is actually inseparable from the strong support of CZ and Solana Foundation. They have promoted people's discovery of this narrative. The market is about to enter the January market. In this intensive coin issuance season, it will be a big test for the coin price.

I hope this content is helpful to you, thank you for reading.